Best practices for managing quality and safety of foreign particles in orally inhaled and nasal drug products, and an evaluation of clinical relevance.
Blanchard
James
J
International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS), Washington, DC, USA.
Coleman
James
J
Crim
Courtney
C
Dabreu-Hayling
Claire
C
Fries
Lou
L
Ghaderi
Raouf
R
Haeberlin
Barbara
B
Malcolmson
Richard
R
Mittelman
Stanley
S
Nagao
Lee
L
Saracovan
Ilie
I
Shtohryn
Liuda
L
Snodgrass-Pilla
Caesar
C
Sundahl
Mikael
M
Wolff
Ronald
R
D000280:Administration, Inhalation; D000281:Administration, Intranasal; D004340:Drug Contamination / Q000517:prevention & control*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000139:chemically induced / Q000517:prevention & control*; D006801:Humans; D010316:Particle Size; D004364:Pharmaceutical Preparations / Q000008:administration & dosage* / Q000737:chemistry; D011786:Quality Control
D004364:Pharmaceutical Preparations